Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

254
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
254

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodies.

Frontiers in immunology·2026
Same author

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses.

Vaccines·2026
Same author

Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreak.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

From silos to synergies: harnessing the power of sexual health data sources in England to understand changing epidemiology and inform policy.

Sexually transmitted infections·2026
Same author

Inequalities in adolescent HPV, Td/IPV and MenACWY vaccination coverage by socio-economic status: an ecological study, England, 2017 to 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Identification of multiple Acinetobacter baumannii protein antigens as targets for potential immunotherapies using a novel protein microarray screening approach.

PLoS pathogens·2026
Same journal

Optimized intracellular flow cytometry panel enables CD4 and CD8 T cell cytokine profiling in Syrian hamsters.

Journal of immunological methods·2026
Same journal

Isosulfan blue sentinel lymph node biopsy enables reliable lymph node harvest and multicolor flow cytometry in mice.

Journal of immunological methods·2026
Same journal

Type-specific antibody detection of herpes simplex virus types 1&2 (HSV-1&2) in fingerstick blood at point-of-care sites by a rapid and sensitive lateral flow immunochromatographic assay.

Journal of immunological methods·2026
Same journal

Development of chimeric DGP-IgG antibodies as quality control for celiac disease diagnosis.

Journal of immunological methods·2026
Same journal

Stepwise single-cell-resolved deep immunophenotyping pipeline to characterise immune heterogeneity and functionality in health and disease.

Journal of immunological methods·2026
Same journal

Performance evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2.

Journal of immunological methods·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

12.8K

Chlamydia trachomatis pgp3 ELISA.

Filomeno Coelho da Silva1, Gathoni Kamuyu1, Kazutomo Yokoya1

  • 1Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK.

Journal of Immunological Methods
|May 15, 2025
PubMed
Summary
This summary is machine-generated.

This study developed a reliable ELISA test to measure antibodies against Chlamydia trachomatis (Ct) pgp3 antigen. This assay supports public health surveillance for Ct infections.

Keywords:
AntibodyChlamydia trachomatisSerologypgp3

More Related Videos

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

7.5K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

12.9K

Related Experiment Videos

Last Updated: May 21, 2025

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

12.8K
Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

7.5K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

12.9K

Area of Science:

  • Immunology
  • Microbiology
  • Public Health

Background:

  • Chlamydia trachomatis (Ct) serology is crucial for population surveillance.
  • Lack of standardized reference reagents and commercial assays hinders effective Ct serosurveillance.
  • There is a need for reliable methods to estimate antibody levels against Ct virulence factors.

Purpose of the Study:

  • To develop an internally standardized Enzyme-Linked Immunosorbent Assay (ELISA) for estimating antibody levels against the Ct virulence factor antigen, pgp3.
  • To establish a robust assay for Chlamydia trachomatis serosurveillance.
  • To provide a method for quantifying antibody levels in AU/mL, adaptable for future international reference standards.

Main Methods:

  • Purification and characterization of trimeric pgp3 antigen.
  • Development and validation of an internally standardized ELISA.
  • Assessment of assay stability, internal standard, quality controls, and repeatability metrics.
  • Evaluation of assay specificity and sensitivity using serum samples from children and females with a history of chlamydia infection.

Main Results:

  • The purified pgp3 antigen demonstrated stability.
  • The internally standardized ELISA exhibited robust quality control and repeatability metrics (Kappa 0.933).
  • The assay achieved excellent specificity (99.4%) and adequate sensitivity (67.9%) for surveillance purposes.
  • Results are reported in antibody levels (AU/mL), allowing for future recalibration.

Conclusions:

  • The developed pgp3 ELISA is a stable and reproducible assay suitable for Chlamydia trachomatis serosurveillance.
  • The assay provides a valuable tool for estimating antibody levels and supporting public health efforts.
  • The standardized reporting in AU/mL ensures adaptability for future reference standards.